How Is Pfizer’s Stock Performance Compared to Other Healthcare Stocks?
With a market cap of $149.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, manufactures,…
Thinning revenues: inside the $14bn Eliquis patent cliff
Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent…
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
Some investors have watched their healthcare stock holdings drop in value recently or over the years, yet they…
Medication cost prevents cancer patient from accessing treatment
GOSNELL, Ark. (KAIT) – Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide —…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Nektar, continuing comeback, says eczema drug’s effects hold up in follow-up study
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…